We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




15-Minute Blood Test Diagnoses Life-Threatening Infections in Children

By HospiMedica International staff writers
Posted on 14 Nov 2025

Distinguishing minor childhood illnesses from potentially life-threatening infections such as sepsis or meningitis remains a major challenge in emergency care. More...

Traditional tests can take hours, leaving clinicians to rely on their judgement or prescribe precautionary antibiotics while awaiting results. Now, a new trial is evaluating a rapid 15-minute blood test designed to identify whether an infection is viral or bacterial, enabling faster and more accurate treatment decisions for children.

The trial, which is underway at three hospitals in the UK, including St Mary’s Hospital, Imperial College Healthcare NHS Trust (London, UK), runs until March 2026 and involves testing children who arrive at emergency departments with fever or suspected infection. The new test provides clinicians with crucial diagnostic clarity in just 15 minutes.

By showing whether an infection is bacterial or viral, it offers an important advantage over conventional laboratory testing, which can take several hours to produce results. Faster diagnosis means patients can be treated sooner and antibiotics can be reserved for cases where they are truly needed, reducing the risk of missed serious infections while also preventing unnecessary prescribing.

The trial aims to understand how real-world emergency teams will use this rapid test and whether it improves safety and decision-making. Current practice often forces clinicians to make assumptions while waiting for lab results, sometimes leading to under- or over-treatment. With a quick point-of-care reading, the new test could help avoid delays in identifying children who require urgent intervention.

The potential impact extends beyond individual diagnoses. Fever is one of the most common reasons children visit emergency departments, and many are prescribed antibiotics unnecessarily. A reliable rapid test could reduce avoidable antibiotic use, improve early detection of serious infections, and support efforts to combat antimicrobial resistance.

“This trial will now tell us whether the test has a role in the NHS and if clinicians will use it to help make faster, more accurate decisions so children receive the right treatment faster,” said Dr Ruud Nijman, pediatric consultant at St Mary’s Hospital and honorary clinical senior lecturer at Imperial College London. “If successful, this test has the potential to completely change the way we treat infections and help us diagnose with more certainty, stopping illnesses escalating to something more serious.

Related Links:
St Mary’s Hospital, Imperial College Healthcare NHS Trust


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.